Zafirlukast Tablet, Film Coated
Product Images NDC 31722-008

5 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zafirlukast (NDC 31722-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

10 mg (10 mg)

10 mg (10 mg)
Zafirlukast 10 mg film-coated tablets label from Camber Pharmaceuticals, Inc., containing 60 tablets in an airtight container. The label includes dosage strength, NDC 31722-007-60, storage instructions, a warning to keep out of reach of children, and manufacturer information from Annora Pharma Pvt. Ltd., India.*
FDA Label Image

20 mg (20 mg)

20 mg (20 mg)
Zafirlukast 20 mg film-coated tablets label by Camber Pharmaceuticals, Inc. The label states 60 tablets in the package with instructions to dispense in the original airtight container. It includes storage instructions, warnings, contact information, and manufacturer details. A barcode is displayed on the right side of the label.*
FDA Label Image

Camber (Camber)

Camber (Camber)
FDA Label Image

Zafirlukastfig (Zafirlukastfig)

Zafirlukastfig (Zafirlukastfig)
A line graph comparing mean beta-2 agonist use (puffs per day) across trial weeks for three groups: placebo, Zafirlukast 20 mg twice daily, and Cromolyn sodium 1600 mcg four times daily. The y-axis shows adjusted treatment means from 2 to 6 puffs/day, and the x-axis covers trial weeks from 0 to 14. The graph indicates changes over time for each group.*
FDA Label Image

Zafirlukaststructure (Zafirlukaststructure)

Zafirlukaststructure (Zafirlukaststructure)
Chemical structure diagram of the active ingredient Zafirlukast as shown in the product data. The diagram depicts the molecular arrangement of Zafirlukast.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.